RCKT Annual Shareholders Equity
$492.57 M
+$2.89 M+0.59%
31 December 2023
Summary:
As of January 22, 2025, RCKT annual stockholders equity is $492.57 million, with the most recent change of +$2.89 million (+0.59%) on December 31, 2023. During the last 3 years, it has fallen by -$10.95 million (-2.17%). RCKT annual shareholders equity is now -2.17% below its all-time high of $503.52 million, reached on December 31, 2020.RCKT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RCKT Quarterly Shareholders Equity
$329.77 M
-$54.86 M-14.26%
30 September 2024
Summary:
As of January 22, 2025, RCKT quarterly stockholders equity is $329.77 million, with the most recent change of -$54.86 million (-14.26%) on September 30, 2024. Over the past year, it has dropped by -$211.31 million (-39.05%). RCKT quarterly shareholders equity is now -39.05% below its all-time high of $541.09 million, reached on September 30, 2023.RCKT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RCKT Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.6% | -39.0% |
| 3 y3 years | -2.2% | -39.0% |
| 5 y5 years | +153.9% | -39.0% |
RCKT Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +8.3% | -39.0% | at low |
| 5 y | 5-year | -2.2% | +60.3% | -39.0% | +36.4% |
| alltime | all time | -2.2% | +1055.4% | -39.0% | +739.6% |
Rocket Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $329.77 M(-14.3%) |
| June 2024 | - | $384.63 M(-12.9%) |
| Mar 2024 | - | $441.50 M(-10.4%) |
| Dec 2023 | $492.57 M(+0.6%) | $492.57 M(-9.0%) |
| Sept 2023 | - | $541.09 M(+34.3%) |
| June 2023 | - | $402.97 M(-12.2%) |
| Mar 2023 | - | $458.88 M(-6.3%) |
| Dec 2022 | $489.69 M(+7.7%) | $489.69 M(+33.3%) |
| Sept 2022 | - | $367.31 M(-5.3%) |
| June 2022 | - | $387.70 M(-7.2%) |
| Mar 2022 | - | $417.62 M(-8.2%) |
| Dec 2021 | $454.72 M(-9.7%) | $454.72 M(-6.4%) |
| Sept 2021 | - | $485.66 M(-0.8%) |
| June 2021 | - | $489.44 M(+2.0%) |
| Mar 2021 | - | $480.00 M(-4.7%) |
| Dec 2020 | $503.52 M(+63.9%) | $503.52 M(+108.2%) |
| Sept 2020 | - | $241.84 M(-9.3%) |
| June 2020 | - | $266.52 M(-6.8%) |
| Mar 2020 | - | $286.05 M(-6.9%) |
| Dec 2019 | $307.30 M | $307.30 M(+32.5%) |
| Sept 2019 | - | $231.92 M(-6.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $248.50 M(+40.3%) |
| Mar 2019 | - | $177.08 M(-8.7%) |
| Dec 2018 | $194.04 M(+306.2%) | $194.04 M(+35.1%) |
| Sept 2018 | - | $143.62 M(-8.6%) |
| June 2018 | - | $157.08 M(-7.7%) |
| Mar 2018 | - | $170.15 M(+256.2%) |
| Dec 2017 | $47.76 M(-34.7%) | $47.76 M(-6.5%) |
| Sept 2017 | - | $51.08 M(-11.2%) |
| June 2017 | - | $57.53 M(-9.1%) |
| Mar 2017 | - | $63.26 M(-13.5%) |
| Dec 2016 | $73.17 M(-32.8%) | $73.17 M(-14.0%) |
| Sept 2016 | - | $85.05 M(-10.9%) |
| June 2016 | - | $95.44 M(-3.8%) |
| Mar 2016 | - | $99.24 M(-8.8%) |
| Dec 2015 | $108.81 M(-311.0%) | $108.81 M(-6.6%) |
| Sept 2015 | - | $116.47 M(+267.2%) |
| June 2015 | - | $31.72 M(-6.6%) |
| Mar 2015 | - | $33.95 M(-165.9%) |
| Dec 2014 | -$51.56 M(+32.6%) | -$51.56 M(>+9900.0%) |
| Sept 2014 | - | -$316.00 K(-99.2%) |
| Dec 2013 | -$38.90 M(+25.8%) | -$38.90 M |
| Dec 2012 | -$30.93 M | - |
FAQ
- What is Rocket Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals annual shareholders equity year-on-year change?
- What is Rocket Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Rocket Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of RCKT is $492.57 M
What is the all time high annual shareholders equity for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high annual stockholders equity is $503.52 M
What is Rocket Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, RCKT annual stockholders equity has changed by +$2.89 M (+0.59%)
What is Rocket Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of RCKT is $329.77 M
What is the all time high quarterly shareholders equity for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high quarterly stockholders equity is $541.09 M
What is Rocket Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, RCKT quarterly stockholders equity has changed by -$211.31 M (-39.05%)